These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18581750)

  • 21. Does chronic warfarin cause increased blood loss and transfusion during lumbar spinal surgery?
    Young EY; Ahmadinia K; Bajwa N; Ahn NU
    Spine J; 2013 Oct; 13(10):1253-8. PubMed ID: 23871508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
    Shah HR; Ledbetter L; Diasio R; Saif MW
    Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arthroscopy on anticoagulated patients: a retrospective evaluation of postoperative complications.
    Flanigan DC; Muchow R; Orwin J; Graf B
    Orthopedics; 2010 Feb; 33(2):82-6. PubMed ID: 20192141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery.
    Katada Y; Nakagawa S; Minakata K; Odaka M; Taue H; Sato Y; Yonezawa A; Kayano Y; Yano I; Nakatsu T; Sakamoto K; Uehara K; Sakaguchi H; Yamazaki K; Minatoya K; Sakata R; Matsubara K
    J Clin Pharm Ther; 2017 Oct; 42(5):591-597. PubMed ID: 28503837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Uninterrupted Warfarin on Hand and Wrist Surgery.
    Bogunovic L; Gelberman RH; Goldfarb CA; Boyer MI; Calfee RP
    J Hand Surg Am; 2015 Nov; 40(11):2133-40. PubMed ID: 26432767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy.
    Irwin AN; McCool KH; Delate T; Witt DM
    Pharmacotherapy; 2013 Nov; 33(11):1175-83. PubMed ID: 23744816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.
    Pengo V; Banzato A; Garelli E; Zasso A; Biasiolo A
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):739-41. PubMed ID: 8292723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can warfarin be continued during dental extraction? Results of a randomized controlled trial.
    Evans IL; Sayers MS; Gibbons AJ; Price G; Snooks H; Sugar AW
    Br J Oral Maxillofac Surg; 2002 Jun; 40(3):248-52. PubMed ID: 12054719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery.
    Al-Belasy FA; Amer MZ
    J Oral Maxillofac Surg; 2003 Dec; 61(12):1405-9. PubMed ID: 14663804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new regimen for starting warfarin therapy in out-patients.
    Oates A; Jackson PR; Austin CA; Channer KS
    Br J Clin Pharmacol; 1998 Aug; 46(2):157-61. PubMed ID: 9723825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
    Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
    Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation status using thromboelastography in patients receiving warfarin prophylaxis and epidural analgesia.
    Hepner DL; Concepcion M; Bhavani-Shankar K
    J Clin Anesth; 2002 Sep; 14(6):405-10. PubMed ID: 12393106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin management in patients on continuous anticoagulation therapy undergoing total knee replacement.
    Chana R; Salmon L; Waller A; Pinczewski L
    J Bone Joint Surg Br; 2011 Nov; 93(11):1497-502. PubMed ID: 22058301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
    Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.